ML-098 is primarily utilized in biochemical research as a potent and selective inhibitor of the enzyme soluble epoxide hydrolase (sEH). This enzyme plays a significant role in the metabolism of epoxy fatty acids, which are involved in various physiological processes, including inflammation and vascular function. By inhibiting sEH, ML-098 helps researchers study the effects of increased epoxy fatty acid levels, particularly in the context of anti-inflammatory and cardiovascular research. Its application is crucial in developing potential therapeutic strategies for conditions such as hypertension, atherosclerosis, and chronic inflammatory diseases. Additionally, ML-098 is used in pharmacological studies to explore the broader implications of sEH inhibition in pain management and neuroprotection.